Chiron Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,303	Closed	-$180K	–	182
2023 Q1	$180K	Buy	+1,303	New	+$180K	0.03%	103
2022 Q4	–	Sell	-1,217	Closed	-$135K	–	170
2022 Q3	$135K	Buy	+1,217	New	+$135K	0.03%	109